Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novocure Ltd | 1 | 1 | 0 | 0 | €15.38 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €75.84 | €100.00 | 31.857% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.62 | €6.45 | 298.309% |
| AnaptysBio Inc | 8 | 1 | 0 | 0 | €23.40 | €45.21 | 93.205% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €6.20 | €19.50 | 214.746% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | €40.40 | €46.08 | 14.066% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €178.00 | €182.79 | 2.691% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €1.92 | €4.39 | 128.833% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €10.33 | €27.02 | 161.660% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 1 | 1 | €38.20 | €43.87 | 14.840% |
| Exelixis Inc. | 19 | 0 | 1 | 0 | €20.17 | €26.01 | 28.936% |
| Innoviva Inc. | 4 | 0 | 1 | 0 | €15.20 | €30.00 | 97.368% |
| Zoetis Inc. A | 24 | 1 | 1 | 0 | €161.72 | €198.11 | 22.503% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.12 | €2.40 | 114.095% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 1 | 0 | €37.40 | €85.51 | 128.640% |
| Madrigal Pharmaceuticals inc. | 4 | 0 | 1 | 0 | €266.30 | €320.00 | 20.165% |
| Chromadex Corp | 10 | 1 | 1 | 0 | €2.34 | €5.55 | 137.333% |
| Heron Therapeutics Inc. | 12 | 1 | 1 | 0 | €2.74 | €4.60 | 67.920% |
| Ardelyx Inc. | 2 | 1 | 1 | 1 | €5.00 | €11.00 | 120.132% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 1 | 0 | €77.02 | €103.66 | 34.586% |
| Adverum Biotechnologies Inc. | 8 | 0 | 1 | 0 | €1.38 | €13.07 | 847.449% |
| Abeona Therapeutics Inc. | 5 | 1 | 1 | 0 | €4.86 | €26.52 | 445.658% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.46 | €18.50 | 651.951% |
| Geron Corp. | 16 | 0 | 2 | 0 | €4.20 | €5.57 | 32.636% |